Abstract
We report a case of late-onset predominantly axonal Charcot-Marie-Tooth disease resulting from a novel mutation in the MPZ gene encoding myelin protein zero (P0). Neurological examination, electrophysiological examination and genetic testing were performed on three members of a Finnish family (family A) and one member of a German family (family B). Three other members of the Finnish family were interviewed and genetically tested. Genetic testing was also performed on 95 healthy Finnish controls. Three members in two generations of family A and the member of family B were affected with late-onset axonal more than demyelinating, motor and sensory polyneuropathy. Heterozygous c.316C>T mutation in MPZ leading to p.Arg106Cys in P0 was found in all the affected subjects, but not in the three unaffected members of the Finnish family. None of 95 healthy Finnish controls harbored the mutation. The findings of this study indicate that p.Arg106Cys allele in MPZ causes late-onset predominantly axonal sensory and motor neuropathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Pareyson D, Marchesi C (2009) Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol 8:654–667
Shy ME, Lupski JR, Chance PF et al (2005) Hereditary motor and sensory neuropathies: an overview of clinical, genetic, electrophysiologic, and pathologic features. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier Saunders, Philadelphia, pp 1623–1658
Bienfait HM, Baas F, Koelman JH et al (2007) Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology 68:1658–1667
Banchs I, Casasnovas C, Alberti A et al (2009) Diagnosis of Charcot-Marie-Tooth disease. J Biomed Biotechnol 2009:985415
Reilly MM, Shy ME (2009) Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatr 80:1304–1314
Lawson VH, Graham BV, Flanigan KM (2005) Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Neurology 65:197–204
Verhoeven K, De Jonghe P, Coen K et al (2003) Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 72:722–727
Szabo A, Zuchner S, Siska E et al (2005) Marked phenotypic variation in a family with a new myelin protein zero mutation. Neuromuscul Disord 15:760–763
Hayasaka K, Nanao K, Tahara M et al (1991) Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral myelin. Biochem Biophys Res Commun 180:515–518
Shy ME, Jani A, Krajewski K et al (2004) Phenotypic clustering in MPZ mutations. Brain 127:371–384
Shy ME (2006) Peripheral neuropathies caused by mutations in the myelin protein zero. J Neurol Sci 242:55–66
Shy ME, Blake J, Krajewski K et al (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214
Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365–386
Bell J (2008) A simple way to treat PCR products prior to sequencing using ExoSAP-IT. Biotechniques 44:834
Körkkö J, Annunen S, Pihlajamaa T et al (1998) Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci USA 95:1681–1685
De Jonghe P, Timmerman V, Ceuterick C et al (1999) The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 122:281–290
Ceroni A, Passerini A, Vullo A et al (2006) DISULFIND: a disulfide bonding state and cysteine connectivity prediction server. Nucleic Acids Res 34(Suppl 2):W177–W181
Rouger H, LeGuern E, Gouider R et al (1996) High frequency of mutations in codon 98 of the peripheral myelin protein P0 gene in 20 French CMT1 patients. Am J Hum Genet 58:638–641
Souayah N, Tick Chong PS (2010) Asymmetric phenotype associated with rare myelin protein zero mutation. J Clin Neuromuscul Dis 11:110–113
Boerkoel CF, Takashima H, Garcia CA et al (2002) Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 51:190–201
Lee YC, Yu CT, Lin KP et al (2008) MPZ mutation G123S characterization: evidence for a complex pathogenesis in CMT disease. Neurology 70:273–277
Acknowledgments
The work was supported by grants from the Research Council for Health at the Academy of Finland and the Sigrid Juselius Foundation.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marttila, M., Rautenstrauss, B., Huehne, K. et al. A novel mutation of myelin protein zero associated with late-onset predominantly axonal Charcot-Marie-Tooth disease. J Neurol 259, 1585–1589 (2012). https://doi.org/10.1007/s00415-011-6382-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-011-6382-5